BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 15544872)

  • 1. Folate-receptor-targeted delivery of doxorubicin nano-aggregates stabilized by doxorubicin-PEG-folate conjugate.
    Yoo HS; Park TG
    J Control Release; 2004 Nov; 100(2):247-56. PubMed ID: 15544872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folate receptor targeted biodegradable polymeric doxorubicin micelles.
    Yoo HS; Park TG
    J Control Release; 2004 Apr; 96(2):273-83. PubMed ID: 15081218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of folate receptor-targeted doxorubicin delivery systems: dosing regimens and therapeutic index.
    Scomparin A; Salmaso S; Eldar-Boock A; Ben-Shushan D; Ferber S; Tiram G; Shmeeda H; Landa-Rouben N; Leor J; Caliceti P; Gabizon A; Satchi-Fainaro R
    J Control Release; 2015 Jun; 208():106-20. PubMed ID: 25869964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folate-receptor-targeted delivery of docetaxel nanoparticles prepared by PLGA-PEG-folate conjugate.
    Esmaeili F; Ghahremani MH; Ostad SN; Atyabi F; Seyedabadi M; Malekshahi MR; Amini M; Dinarvand R
    J Drug Target; 2008 Jun; 16(5):415-23. PubMed ID: 18569286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved therapeutic activity of folate-targeted liposomal doxorubicin in folate receptor-expressing tumor models.
    Gabizon A; Tzemach D; Gorin J; Mak L; Amitay Y; Shmeeda H; Zalipsky S
    Cancer Chemother Pharmacol; 2010 May; 66(1):43-52. PubMed ID: 19779718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor activity of a folate receptor-targeted immunoglobulin G-doxorubicin conjugate.
    Yang T; Xu L; Li B; Li W; Ma X; Fan L; Lee RJ; Xu C; Xiang G
    Int J Nanomedicine; 2017; 12():2505-2515. PubMed ID: 28408821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of folate receptor-targeted and Doxorubicin-coupled chemotherapeutic nanoconjugate and research into its medical applications.
    Ak G; Sanlıer SH
    Prep Biochem Biotechnol; 2012; 42(6):551-63. PubMed ID: 23030466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of a novel ligand for folate-mediated targeting liposomes.
    Xiang G; Wu J; Lu Y; Liu Z; Lee RJ
    Int J Pharm; 2008 May; 356(1-2):29-36. PubMed ID: 18258394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doxorubicin loaded pH-sensitive micelle: antitumoral efficacy against ovarian A2780/DOXR tumor.
    Kim D; Lee ES; Park K; Kwon IC; Bae YH
    Pharm Res; 2008 Sep; 25(9):2074-82. PubMed ID: 18449626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folate receptor-targeted multimodal polymersomes for delivery of quantum dots and doxorubicin to breast adenocarcinoma: In vitro and in vivo evaluation.
    Alibolandi M; Abnous K; Sadeghi F; Hosseinkhani H; Ramezani M; Hadizadeh F
    Int J Pharm; 2016 Mar; 500(1-2):162-78. PubMed ID: 26802496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relevance of folic acid/polymer ratio in targeted PEG-epirubicin conjugates.
    Canal F; Vicent MJ; Pasut G; Schiavon O
    J Control Release; 2010 Sep; 146(3):388-99. PubMed ID: 20621587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor effect of folate-targeted liposomal doxorubicin in KB tumor-bearing mice after intravenous administration.
    Riviere K; Huang Z; Jerger K; Macaraeg N; Szoka FC
    J Drug Target; 2011 Jan; 19(1):14-24. PubMed ID: 20353291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Target-specific cellular uptake of PLGA nanoparticles coated with poly(L-lysine)-poly(ethylene glycol)-folate conjugate.
    Kim SH; Jeong JH; Chun KW; Park TG
    Langmuir; 2005 Sep; 21(19):8852-7. PubMed ID: 16142970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folate receptor mediated intracellular protein delivery using PLL-PEG-FOL conjugate.
    Hwa Kim S; Hoon Jeong J; Joe CO; Gwan Park T
    J Control Release; 2005 Apr; 103(3):625-34. PubMed ID: 15820409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Target-specific cellular uptake of taxol-loaded heparin-PEG-folate nanoparticles.
    Wang Y; Wang Y; Xiang J; Yao K
    Biomacromolecules; 2010 Dec; 11(12):3531-8. PubMed ID: 21086982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addition of TPGS to folate-conjugated polymer micelles for selective tumor targeting.
    Zhao H; Yung LY
    J Biomed Mater Res A; 2009 Nov; 91(2):505-18. PubMed ID: 18985763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selectivity of folate conjugated polymer micelles against different tumor cells.
    Zhao H; Yung LY
    Int J Pharm; 2008 Feb; 349(1-2):256-68. PubMed ID: 17850996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel folated and non-folated pullulan bioconjugates for anticancer drug delivery.
    Scomparin A; Salmaso S; Bersani S; Satchi-Fainaro R; Caliceti P
    Eur J Pharm Sci; 2011 Apr; 42(5):547-58. PubMed ID: 21371555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folate-mediated poly(3-hydroxybutyrate-co-3-hydroxyoctanoate) nanoparticles for targeting drug delivery.
    Zhang C; Zhao L; Dong Y; Zhang X; Lin J; Chen Z
    Eur J Pharm Biopharm; 2010 Sep; 76(1):10-6. PubMed ID: 20472060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and grafting of thioctic acid-PEG-folate conjugates onto Au nanoparticles for selective targeting of folate receptor-positive tumor cells.
    Dixit V; Van den Bossche J; Sherman DM; Thompson DH; Andres RP
    Bioconjug Chem; 2006; 17(3):603-9. PubMed ID: 16704197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.